Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy Academic Article uri icon

Overview

MeSH Major

  • Anti-HIV Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • HIV Infections
  • Lymphoma, AIDS-Related
  • Lymphoma, Non-Hodgkin

abstract

  • Either modified-dose or full-dose CHOP chemotherapy for HIV-NHL, delivered with HAART, is effective and tolerable.

publication date

  • April 15, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11304769

Additional Document Info

start page

  • 2171

end page

  • 8

volume

  • 19

number

  • 8